Apg Labs

Apg Labs was paid $4.66M by Medicaid between Jan 2018 and Dec 2024, across 2 billing codes. Its largest line is G0481, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed — 72% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Maryland

Rank by total paid#16 of 93

Median peer was paid$430K

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	16,868	$1.47M
2019	11,125	$926K
2020	2,628	$239K
2021	4,652	$456K
2022	7,250	$713K
2023	5,948	$550K
2024incomplete	3,350	$310K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	72%	27,263	13,040	$3.37M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	28%	24,558	11,015	$1.29M

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSAEED, IRFAN (CEO)

Same official

Other billing entities under SAEED, IRFAN

Full network →

Provider	Location	Paid
American Psychiatric Group, P.A.	Baltimore, MD	$1.89M
American Psychiatric Group PA	Baltimore, MD	$653K
American Psychiatric Group PA	Baltimore, MD	$131K
American Psychiatric Group, P.A.	Baltimore, MD	$94K
American Psychiatric Group PA	Columbia, MD	$82K
American Psychiatric Group, P.A.	Baltimore, MD	$17K
American Psychiatric Group PA	Baltimore, MD	$4K
American Psychiatric Group, P.A.	Baltimore, MD	$3K
American Psychiatric Group, PA	Baltimore, MD	$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.